Latest Strategy Changes News

Unibail-Rodamco-Westfield will voluntarily delist from the ASX by late August 2025, citing low liquidity and rising compliance costs. Australian investors holding CHESS Depositary Interests face key decisions on how to manage their holdings.

I Synergy Group Limited has successfully raised approximately $1 million through a fully underwritten entitlement offer, with robust shareholder participation and full underwriting support.

Westpac Banking Corporation announces a fully franked distribution of AUD 1.2463 per Capital Note 7 for Q3 2025, reflecting a 4.9447% annualised rate based on the 3-month BBSW plus margin.

North Stawell Minerals reports promising high-grade gold intercepts at its Darlington target within the Stawell Mineralised Corridor, backed by a $3.6 million capital raise to accelerate exploration.

Duxton Farms announces a transformative merger with four private agricultural companies, alongside a $4 million fully underwritten placement and a special dividend, aiming to significantly expand its asset base and diversify its portfolio.

FirstWave Cloud Technology has renewed its key email security agreement with Telstra, securing ISM-compliant services for federal agencies while preparing for a notable revenue decline offset by cost savings and growth via AWS.

Duxton Farms Ltd is set to transform its agricultural portfolio through a strategic merger with four private companies, alongside a $4 million placement and a special dividend, aiming to boost scale and diversification.

SunRice reported a slight decline in FY25 revenue to $1.85 billion but achieved improved profitability, driven by strategic acquisitions and operational efficiencies. The company is investing in sustainability and capacity upgrades as it pursues its 2030 Growth Strategy.

Adherium Limited has successfully closed the institutional portion of its entitlement offer, increasing the raise to $4.492 million due to robust demand. The company now invites retail shareholders to participate as it advances its digital respiratory health solutions.

Ricegrowers Limited (SunRice) has reactivated its Dividend Reinvestment Plan for the FY25 final dividend, offering shareholders a discounted share purchase option backed by a $10 million partial underwriting.

SunRice Group reported a 4% rise in net profit for FY25 alongside an 8% dividend increase, navigating inflation and currency volatility with strategic growth initiatives.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology monoclonal antibody targeting VISTA, from Hummingbird Bioscience, marking a strategic pivot after recent setbacks. The company plans to initiate phase II trials in 2026, aiming to advance this novel cancer therapy toward commercialisation.